Krystal Biotech Inc (KRYS)
Financial leverage ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 1,055,840 | 818,355 | 558,450 | 626,295 | 310,844 |
| Total stockholders’ equity | US$ in thousands | 946,380 | 778,641 | 522,231 | 593,576 | 292,084 |
| Financial leverage ratio | 1.12 | 1.05 | 1.07 | 1.06 | 1.06 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $1,055,840K ÷ $946,380K
= 1.12
The financial leverage ratio of Krystal Biotech Inc has been relatively stable over the past five years, ranging from 1.05 to 1.12. This ratio indicates that the company relies moderately on debt financing to fund its operations and growth, with a yearly average of around 1.07. A financial leverage ratio of 1 suggests a balanced capital structure where debt and equity are equally utilized.
Overall, the consistency in the financial leverage ratio of Krystal Biotech Inc suggests a prudent approach to managing its debt levels and maintaining a healthy balance between debt and equity in its capital structure.
Peer comparison
Dec 31, 2024